Aelix Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients (NCT04364035) | Aelix Therapeutics | 2020-02-20 |
Track Aelix Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.